Header cover image

German (DAX) Biotech Industry Analysis

UpdatedJun 07, 2023
DataAggregated Company Financials
Companies18
  • 7D0.5%
  • 3M4.2%
  • 1Y-6.4%
  • YTD-0.6%

Last week, the Biotech industry hasn't moved much but MorphoSys is up 7.0% in that time. As for the longer term, the industry has declined 7.2% in the last year. Looking forward, earnings are forecast to grow by 42% annually.

Industry Valuation and Performance

Has the German Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 07 Jun 2023€4.1b€967.4m-€212,660,026.0031.4x-19.3x4.2x
Fri, 05 May 2023€3.7b€966.0m-€194,145,453.0030x-19x3.8x
Sun, 02 Apr 2023€3.5b€920.1m-€215,284,148.0013.9x-16.1x3.8x
Tue, 28 Feb 2023€3.0b€612.2m-€74,677,325.0010.8x-40.1x4.9x
Thu, 26 Jan 2023€3.0b€611.9m-€53,407,435.0011.1x-56.7x4.9x
Sat, 24 Dec 2022€3.0b€611.9m-€53,407,435.0011x-56.3x4.9x
Mon, 21 Nov 2022€3.0b€611.8m-€48,604,435.0010.6x-60.9x4.8x
Wed, 19 Oct 2022€2.6b€627.4m-€129,805,157.005.3x-19.7x4.1x
Fri, 16 Sep 2022€2.6b€627.4m-€129,805,157.006.1x-20.3x4.2x
Sun, 14 Aug 2022€2.8b€605.5m-€122,397,513.006.3x-22.5x4.5x
Tue, 12 Jul 2022€3.4b€772.2m-€724,268,362.00n/a-4.7x4.4x
Thu, 09 Jun 2022€3.4b€768.8m-€724,082,241.00n/a-4.8x4.5x
Sat, 07 May 2022€3.3b€798.7m-€685,603,111.001.6x-4.8x4.1x
Mon, 04 Apr 2022€3.7b€808.9m-€704,269,813.00n/a-5.2x4.6x
Wed, 02 Mar 2022€3.6b€789.6m-€311,283,353.00n/a-11.4x4.5x
Fri, 28 Jan 2022€3.7b€789.6m-€311,283,353.00n/a-11.8x4.6x
Sun, 26 Dec 2021€4.1b€789.6m-€311,690,565.00n/a-13.1x5.2x
Tue, 23 Nov 2021€4.2b€789.6m-€311,690,565.00n/a-13.6x5.4x
Thu, 21 Oct 2021€4.4b€771.2m-€257,628,521.00n/a-17.3x5.8x
Sat, 18 Sep 2021€4.4b€762.9m-€163,686,446.001.3x-26.6x5.7x
Mon, 16 Aug 2021€4.2b€769.4m-€175,243,228.001.4x-23.9x5.4x
Mon, 31 May 2021€5.0b€742.3m-€215,931,793.001.3x-23x6.7x
Thu, 04 Mar 2021€5.7b€929.7m-€78,349,962.2327.9x-72.9x6.1x
Sun, 06 Dec 2020€5.4b€857.0m-€138,041,722.0268x-39.1x6.3x
Wed, 09 Sep 2020€6.2b€856.0m-€124,654,217.9532.8x-49.7x7.2x
Price to Earnings Ratio

-48.5x


Total Market Cap: €6.0bTotal Earnings: -€122,928,578.95Total Revenue: €854.0mTotal Market Cap vs Earnings and Revenue0%0%0%
German Biotech Industry Price to Earnings3Y Average -30.6x202120222023
Current Industry PE
  • Investors are pessimistic on the German Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.4x is higher than the industry's current PS ratio of 4.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 4.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does German Biotech compare with similar industries?

DE Market0.44%
Healthcare1.56%
Biotech0.54%
Biotech0.54%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MOR MorphoSys€26.7812.7%
+€102.8m
32.6%PS3.1x
VSC 4SC€3.9025.0%
+€7.9m
108.6%PS90.5x
PA8 Paion€6.2512.6%
+€5.0m
-32.1%PS1.3x
20B BioMark Diagnostics€0.2117.5%
+€2.6m
4.0%PS180.2x
ELN Elanix Biotechnologies€0.059,900.0%
+€400.0k
-66.7%n/a
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ECX1

€0.63

Epigenomics

7D

-0.8%

1Y

-67.0%

MOR

€26.78

MorphoSys

7D

12.7%

1Y

32.6%

FYB

€70.40

Formycon

7D

-6.1%

1Y

-11.1%

HPHA

€3.80

Heidelberg Pharma

7D

-1.3%

1Y

-26.6%

MDG1

€1.60

Medigene

7D

-0.9%

1Y

-41.8%

20B

€0.21

BioMark Diagnostics

7D

17.5%

1Y

4.0%

PA8

€6.25

Paion

7D

12.6%

1Y

-32.1%

T5O

€1.93

bioXXmed

7D

-8.1%

1Y

-47.0%

2INV

€6.35

2invest

7D

-1.6%

1Y

-42.5%